| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00390975 Details | 2012-05-04 Interventional | 4 | - | Tegaserod Gastroparesis Diabetes | This study was terminated early as a result of regulatory action suspending tegaserod use in
2007 - | |||
| NCT00332826 Details | 2012-05-04 Interventional | 3 | 3 | Insulin Asthma Diabetes Mellit… Diabetes Mellit… Diabetes Mellit… | Non-safety related business decision to combine special population protocols - | |||
| NCT00606099 Details | 2012-05-02 Interventional | 4 | 0 | Adefovir Adefovir dipivo… Telbivudine Hepatitis Hepatitis A Hepatitis B Hepatitis B, Ch… Hepatitis, Chro… Chronic Hepatit… | study was cancelled - | |||
| NCT01313572 Details | 2012-05-01 Interventional | 3 | 197 | Adenosine Coronary Artery… Coronary Diseas… Myocardial Isch… | - - | |||
| NCT00990327 Details | 2012-05-01 Interventional | 3 | 863 | Adenosine Coronary Artery… Coronary Diseas… Myocardial Isch… | - - | |||
| NCT00399659 Details | 2012-05-01 Interventional | 3 | 360 | Tegaserod Constipation Opioid-Induced … Opioid-induced … | This study was terminated early as a result of regulatory action suspending tegaserod use in
2007 - | |||
| NCT00248157 Details | 2012-05-01 Interventional | 3 | 105 | Octreotide Diabetic Retino… Retinal Disease… | Inconsistent treatment benefit - | |||
| NCT00171860 Details | 2012-05-01 Interventional | 2 | 24 | Imatinib Mesyla… Hypereosinophil… Syndrome | - - | |||
| NCT00601978 Details | 2012-04-30 Interventional | 4 | 0 | Carbidopa Carbidopa, levo… Entacapone Levodopa Parkinson Disea… Parkinson's Dis… | Business decision brand strategy; no patients enrolled - | |||
| NCT00386750 Details | 2012-04-27 Interventional | 4 | - | Artemether Artemether, Lum… Lumefantrine Malaria Falciparum | - - | |||
| NCT00369395 Details | 2012-04-27 Interventional | 2 | 19 | Volociximab Melanoma Stage IV Melano… | Insufficient clinical activity - | |||
| NCT00343512 Details | 2012-04-27 Interventional | 2 | 34 | Docetaxel Breast Neoplasm… Breast Cancer | closed due to competing neoadjuvant studies for a small patient population All adverse events have been included in the "other adverse event" section. They are not differentiated by causality (eg. related to disease, con-meds). | |||
| NCT00307827 2005-003482-17 Details | 2012-04-27 Interventional | 2 | 38 | Visilizumab Colitis Colitis, Ulcera… Ulcer Ulcerative Coli… | Study Canceled - | |||
| NCT00100685 NCT00103077 Details | 2012-04-27 Interventional | 2 | 48 | Antibodies Antibodies, Mon… Volociximab Carcinoma Carcinoma, Rena… Metastases Renal Cell Carc… | - - | |||
| NCT00299234 Details | 2012-04-26 Interventional | 4 | 1 | Atomoxetine Hyd… Attention Defic… Hyperkinesis Attention Defic… | Insufficient number of interested potentital subjects - | |||
| NCT00242541 Details | 2012-04-26 Interventional | 4 | 50 | Octreotide Acromegaly | - - | |||
| NCT00930995 Details | 2012-04-25 Interventional | 2 | 0 | Candesartan Candesartan cil… Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… | Not Awarded - | |||
| NCT00670696 Details | 2012-04-25 Interventional | 4 | 0 | Tetracaine Anesthesia Healthy | No longer sponsor of trial - | |||
| NCT00442741 Details | 2012-04-25 Interventional | 1 | 0 | Epothilone B Epothilones Omeprazole Neoplasms Solid Tumors | pts. will be captured in core - | |||
| NCT01169857 Details | 2012-04-24 Interventional | 4 | 0 | Bortezomib Proteasome Inhi… Hematuria Lupus Nephritis Nephritis Proteinuria | No participants were enrolled. - |